Personalised Medicine

Access ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.

Tumour Knowledge Portal

Preselected recommended educational resources on this topic

ESMO Precision Medicine Glossary
Published in 2017 - Ann Oncol (2017) doi: 10.1093/annonc/mdx707

Watch Lucy Yates explain why this glossary was developped (video)

Latest News and video interviews

20 Oct 2018 ESMO 2018 Congress: Highlights in metastatic triple negative breast cancer IMpassion130

30 Oct 2018 ESMO 2018 Expert Video Report on Ovarian Cancer

15 Jun 2018 Perspectives from ASCO 2018: Immunotherapy research in oncogene driven NSCLC, The ImmunoTarget and early combination study

15 Jun 2018 ESMO videos: Perspectives from ASCO 2018

30 May 2018 BRCA Across Tumour Types

E-Learning

21 Jun 2018 V-Learning: BRCA Across Tumour Types Judith Balmaña

11 Oct 2017 V-Learning: Mechanisms of TKI Resistance Luc Friboulet

16 Jun 2017 New Developments in Epigenetics and Potential Clinical Applications Susan Bates

04 Apr 2017 The Role of Circulating Tumour Cells (CTCs) in Cancer Management Klaus Pantel

29 Jan 2016 V-Learning: Personalised Medicine in the Context of Drug Development Hendrik-Tobias Arkenau

More E-Learning modules

Meetings resources on this topic

15 Dec 2018 Anti-MUC1 CAR-T cells combined with PD-1 knockout engineered T cells for patients with non-small cell lung cancer (NSCLC): A pilot study

15 Dec 2018 First-line pembrolizumab monotherapy in metastatic PD-L1 positive non-small cell lung cancer: A real-world analysis of time on treatment in US comm...

15 Dec 2018 A phase Ia/Ib trial of tislelizumab, an anti-PD-1 antibody (ab), in patients (pts) with advanced solid tumors

15 Dec 2018 Somatic mutations in BRCA2, NFE2L2, ARID1A and NOTCH1 sensitize to anti-PDL1 therapy in multiple tumor types

25 Nov 2018 The maximal potential of precision medicine needs to go beyond genomic sequencing

Explore Meeting Resources on this topic

OncologyPRO satisfaction rate is 96% from the result of a June 2018 online survey

Daily News

ESMO Videos

What's new on OncologyPRO?

OncologyPRO structure explained

Clinical Practice Guidelines

Pocket Guidelines & Mobile App

ESMO Consensus Conferences

Practice Tools

Anti-Cancer Agents and Biological Therapy

Bioethics, legal and economic issues

Cancer Aetiology, Epidemiology and Prevention

Cancer Immunology and Immunotherapy

Cancer in Special situations (pregnancy, young, elderly, hereditary...)

Imaging, Diagnosis and Staging

Palliative and Supportive care

Pathology and Molecular Biology